Literature DB >> 8633379

Hepatic Retransplantation--an analysis of risk factors associated with outcome.

H R Doyle1, F Morelli, J McMichael, C Doria, L Aldrighetti, T E Starzl, I R Marino.   

Abstract

Hepatic retransplantation is controversial because the results are inferior to primary transplants and organs are so scarce. To determine the factors that are associated with poor outcome within the first year following retransplantation, we performed a multivariate analysis, using stepwise logistic regression, of 418 hepatic retransplantations performed at a single institution from November 1987 to December 1993. The minimum follow-up was 1 year. Seven variables were found to be independently associated with subsequent graft failure (defined as either patient death or retransplantation): donor age (odds ratio 2.2 for each 10-year increase over age 45, 95% CI 1.3 to 3.7), female donor sex (odds ratio 1.7, 95% CI 1.05 to 2.7), recipient age (odds ratio 1.6 for each 10-year increase over age 45,95% CI 1.2 to 2.8), need for preoperative mechanical ventilation (odds ratio 1.8, 95% CI 1.1 to 2.9), pretransplant serum creatinine (odds ratio 1.24 for each increase of 1 mg/dl, 95% CI 1.1 to 1.4), pretransplant total serum bilirubin (odds ratio 1.4 for each 10-mg/dl increase over 15 mg/dl, 95% CI 1.1 to 1.8), and the primary immunosuppressant, using tacrolimus as the reference category (odds ratio for cyclosporine-based immunosuppression 3.9, 95% CI 2.3 to 6.8). Although not part of the logistic regression model, the timing of retransplantation was also found to be important, with the overall probability of failure increasing from 0.58 on day 0 to a peak of 0.8 on day 38 and decreasing slowly after that. The implications of these results regarding the appropriateness of retransplantation are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8633379      PMCID: PMC2956444          DOI: 10.1097/00007890-199605270-00016

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  28 in total

1.  Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution.

Authors:  H Furukawa; S Todo; O Imventarza; A Casavilla; Y M Wu; C Scotti-Foglieni; B Broznick; J Bryant; R Day; T E Starzl
Journal:  Transplantation       Date:  1991-05       Impact factor: 4.939

2.  Liver retransplantation in adults: overall results and determinant factors affecting the outcome.

Authors:  P Morel; H L Rilo; A G Tzakis; S Todo; R D Gordon; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

3.  A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.

Authors:  J Fung; K Abu-Elmagd; A Jain; R Gordon; A Tzakis; S Todo; S Takaya; M Alessiani; A Demetris; O Bronster
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

4.  Results after liver retransplantation in a group of 50 regrafted patients: two different concepts of elective versus emergency retransplantation.

Authors:  N P Mora; G B Klintmalm; J B Cofer; H Solomon; R M Goldstein; T A Gonwa; B S Husberg
Journal:  Transpl Int       Date:  1991-12       Impact factor: 3.782

5.  Results after liver retransplantation (RETx): a comparative study between "elective" vs "nonelective" RETx.

Authors:  N P Mora; G B Klintmalm; J B Cofer; S S Poplawski; R M Goldstein; T A Gonwa; B S Husberg
Journal:  Transplant Proc       Date:  1990-08       Impact factor: 1.066

6.  Liver transplantation in patients over sixty years of age.

Authors:  A C Stieber; R D Gordon; S Todo; A G Tzakis; J J Fung; A Casavilla; R R Selby; L Mieles; J Reyes; T E Starzl
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

7.  Is retransplantation cost effective?

Authors:  R W Evans; D L Manninen; F B Dong; D A McLynne
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

8.  Hepatic retransplantation in New England--a regional experience and survival model.

Authors:  J A Powelson; A B Cosimi; W D Lewis; R J Rohrer; R B Freeman; J P Vacanti; M Jonas; M I Lorber; W H Marks; J Bradley
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

Review 9.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

10.  Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.

Authors:  P Neuhaus; G Blumhardt; W O Bechstein; K P Platz; S Jonas; A R Mueller; J M Langrehr; R Lohmann; N Schattenfroh; M Knoop
Journal:  Transplantation       Date:  1995-01-15       Impact factor: 4.939

View more
  19 in total

1.  Multivariate regression analysis on early mortality after orthotopic liver transplantation.

Authors:  Ye-Ben Qian; Gui-Hua Cheng; Jie-Fu Huang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era.

Authors:  I R Marino; F Morelli; C Doria; T Gayowski; J McMichael; J J Fung; T E Starzl; H R Doyle
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

3.  Liver retransplantation in adults: a single-centre, 25-year experience.

Authors:  Ravi Marudanayagam; Vivekanandan Shanmugam; Bynvant Sandhu; Bridget K Gunson; Darius F Mirza; David Mayer; John Buckels; Simon R Bramhall
Journal:  HPB (Oxford)       Date:  2010-04       Impact factor: 3.647

4.  Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.

Authors:  R M Ghobrial; D G Farmer; A Baquerizo; S Colquhoun; H R Rosen; H Yersiz; J F Markmann; K E Drazan; C Holt; D Imagawa; L I Goldstein; P Martin; R W Busuttil
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

5.  Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilization.

Authors:  W R Kim; R H Wiesner; J J Poterucha; T M Therneau; M Malinchoc; J T Benson; J S Crippin; G B Klintmalm; J Rakela; T E Starzl; R A Krom; R W Evans; E R Dickson
Journal:  Hepatology       Date:  1999-08       Impact factor: 17.425

6.  A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.

Authors:  R M Ghobrial; R Steadman; J Gornbein; C Lassman; C D Holt; P Chen; D G Farmer; H Yersiz; N Danino; E Collisson; A Baquarizo; S S Han; S Saab; L I Goldstein; J A Donovan; K Esrason; R W Busuttil
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

7.  Predictors of survival after In vivo split liver transplantation: analysis of 110 consecutive patients.

Authors:  R M Ghobrial; H Yersiz; D G Farmer; F Amersi; J Goss; P Chen; S Dawson; S Lerner; N Nissen; D Imagawa; S Colquhoun; W Arnout; S V McDiarmid; R W Busuttil
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

8.  Long-term survival after retransplantation of the liver.

Authors:  J F Markmann; J S Markowitz; H Yersiz; M Morrisey; D G Farmer; D A Farmer; J Goss; R Ghobrial; S V McDiarmid; R Stribling; P Martin; L I Goldstein; P Seu; C Shackleton; R W Busuttil
Journal:  Ann Surg       Date:  1997-10       Impact factor: 12.969

9.  Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience.

Authors:  Ronald W Busuttil; Douglas G Farmer; Hasan Yersiz; Jonathan R Hiatt; Sue V McDiarmid; Leonard I Goldstein; Sammy Saab; Steven Han; Francisco Durazo; Michael Weaver; Carlos Cao; Tony Chen; Gerald S Lipshutz; Curtis Holt; Sherilyn Gordon; Jeffery Gornbein; Farin Amersi; Rafik M Ghobrial
Journal:  Ann Surg       Date:  2005-06       Impact factor: 12.969

10.  Identifying independent risk factors for graft loss after primary liver transplantation.

Authors:  Jill Gwiasda; Harald Schrem; Jürgen Klempnauer; Alexander Kaltenborn
Journal:  Langenbecks Arch Surg       Date:  2017-06-01       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.